Skip to main content

Advertisement

SpringerLink
Log in

Current pharmacologic testing for horner syndrome

  • Published:
Current Neurology and Neuroscience Reports Aims and scope Submit manuscript

Abstract

First described in 1727, Horner syndrome occurs from injury to one of the three neurons in the oculo-sympathetic pathway. Its presence can be confirmed with pharmacologic testing, traditionally including cocaine testing with hydroxyamphetamine localization. More recently, apraclonidine testing has become a viable alternative in some practices. Concern has been raised regarding the possibility of false-negative results with apraclonidine testing as well as the safety of its use in young children.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. du Petit FP: Mémoire dans lequel il est démontré que les nerfs intercostaux fournissent des rameaux que portent des esprits dans les yeux. Paris, Mém: Hist Acad Roy Sci; 1727:1–19.

  2. Bernard C: Des phénomènes oculo-pupillaires produits par la section du nerf sympathique cervical: ils sont indépendants des phénomènes vasculaires calorifiques de la tête. Comptes rendus de l’Académie des Sciences, Paris 1852, 55:381–388.

    Google Scholar 

  3. Weir Mitchell S, Keen W Jr, Morehouse GR: Gunshot Wounds and Other Injuries of Nerves. Philadelphia: Lippincott; 1864. (Reprinted; San Francisco: Norman Publishing; 1989.)

    Google Scholar 

  4. Horner JF: On a form of ptosis. Klin Monatsbl Augenheilkd 1869, 7:193–198.

    Google Scholar 

  5. Amonoo-Kuofi HS: Horner’s syndrome revisited: with an update of the central pathway. Clin Anat 1999, 12:345–361.

    Article  PubMed  CAS  Google Scholar 

  6. Thompson HS. The pupil. In Adler’s Physiology of the Eye, edn 9. Edited by Hart WM Jr. St. Louis: Mosby-Year Book; 1992:412–441.

    Google Scholar 

  7. Burde RM, Savino PJ, Trobe JD: Anisocoria and abnormal papillary light reactions. In Clinical Decisions in Neuroophthalmology, edn 2. Edited by Kist KM. St. Louis: Mosby-Year Book; 1992:321–346.

    Google Scholar 

  8. Snell RS, Lemp MA: Clinical Anatomy of the Eye. Boston: Blackwell Scientific Publications; 1989:297–317.

    Google Scholar 

  9. Pilley SFJ, Thompson HS: Pupillary “dilation lag” in Horner’s syndrome. Br J Ophthalmol 1976, 59:731–735.

    Article  Google Scholar 

  10. Smith G, Dyches TJ, Burden RM: Topographical analysis of Horner syndrome. Otolaryngol Head Neck Surg 1986, 94:451–457.

    PubMed  CAS  Google Scholar 

  11. Weinstein JM, Lweifel TJ, Thompson HS: Congenital Horner’s Syndrome. Arch Ophthalmol 1980, 98:1074–1078.

    PubMed  CAS  Google Scholar 

  12. Morrison DA, Bibby K, Woodruff G: The “harlequin” sign and congenital Horner syndrome. J Neurol Neurosurg Psychiatry 1997, 62:626–628.

    Article  PubMed  CAS  Google Scholar 

  13. Sacco RL, Freddo L, Bello JA, et al.: Wallenberg’s lateral medullary syndrome: clinical-magnetic resonance imaging correlations. Arch Neurol 1993, 50:609–614.

    PubMed  CAS  Google Scholar 

  14. Pomeranz H: Isolated Horner syndrome and syrinx of the cervical spinal cord. Am J Ophthalmol 2002, 133:702–704.

    Article  PubMed  Google Scholar 

  15. Attar S, Krasna MJ, Sonett JR, et al.: Superior sulcus tumor: experience with 105 patients. Ann Thorac Surg 1998, 66:193–198.

    Article  PubMed  CAS  Google Scholar 

  16. Rosner M, Fisher W, Mulligan L: Cervical sympathetic schwannoma: case report. Neurosurgery 2001, 49:1452–1454.

    Article  PubMed  CAS  Google Scholar 

  17. Hood RJ, Jensen ME, Reibel JF, et al.: Schwannoma of the cervical sympathetic chain. Ann Otol Rhinol Laryngol 2000, 109:48–51.

    PubMed  CAS  Google Scholar 

  18. López-Ibor B, Schwartz AD: Neuroblastoma. Pediatr Clin North Am 1985, 32:755–778.

    PubMed  Google Scholar 

  19. Shimada H, Ambros I, Dehner L, et al.: Terminology and morphologic criteria of neuroblastic tumors. Cancer 1999, 86:349–363.

    Article  PubMed  CAS  Google Scholar 

  20. Al-Jassim AH: Cervical ganglioneuroblastoma. J Laryngol Otol 1987, 101:296–301.

    PubMed  CAS  Google Scholar 

  21. Levin R, Newman SA, Login IS: Bilateral Horner syndrome secondary to multinodular goiter. Ann Intern Med 1986, 105:550–551.

    PubMed  CAS  Google Scholar 

  22. Kumar R, Buckley TF: First disc protrusion. Spine 1986, 11:499–501.

    Article  PubMed  CAS  Google Scholar 

  23. Inci S, Bertan V, Kansu T, Cila A: Horner’s syndrome due to jugular venous ectasia. Childs Nerv Syst 1995, 11:533–535.

    Article  PubMed  CAS  Google Scholar 

  24. Delabrousse E, Kastler B, Bernard Y, et al.: MR diagnosis of a congenital abnormality of the thoracic aorta with an aneurysm of the right subclavian artery presenting as a Horner’s syndrome in an adult. Eur Radiol 2000, 10:650–652.

    Article  PubMed  CAS  Google Scholar 

  25. Ekatodramis G, Macaire P, Borgeat A: Prolonged Horner syndrome due to neck hematoma after continuous interscalene block. Anesthesiology 2001, 95:801–803.

    Article  PubMed  CAS  Google Scholar 

  26. Auer D, Karnath HO, Nagele T, et al.: Case report: noninvasive investigation of pericarotid syndrome: role of MR angiography in the diagnosis of internal carotid dissection. Headache 1995, 35:163–168.

    Article  PubMed  CAS  Google Scholar 

  27. Guy N, Deffond D, Gabrillargues J, et al.: Spontaneous internal carotid artery dissection with lower cranial nerve palsy. Can J Neurol Sci 2001, 28:265–269.

    PubMed  CAS  Google Scholar 

  28. Chan CC, Paine M, O’Day J: Carotid dissection: a common cause of Horner syndrome. Clin Experiment Ophthalmol 2001, 29:411–415.

    Article  PubMed  CAS  Google Scholar 

  29. Leira EC, Bendixen BH, Kardon RH, et al.: Brief transient Horner syndrome can be the hallmark of a carotid artery dissection. Neurology 1998, 50:289–290.

    PubMed  CAS  Google Scholar 

  30. Khurana RK: Bilateral Horner syndrome in cluster type headaches. Headache 1993, 33:449–451.

    Article  PubMed  CAS  Google Scholar 

  31. Coley SC, Clifton A, Britton J: Giant aneurysm of the petrous internal carotid artery: diagnosis and treatment. J Laryngol Otol 1998, 112:196–198.

    Article  PubMed  CAS  Google Scholar 

  32. Ryan FH, Kline LB, Gomez C: Congenital Horner syndrome resulting from agenesis of the internal carotid artery. Ophthalmology 2000, 107:185–188.

    Article  PubMed  CAS  Google Scholar 

  33. Kardon RH. The pupils and accommodation. In Principles and Practice of Ophthalmology, edn 2. Edited by Albert DM, Jakobiec FA. Philadelphia: WB Saunders Company; 2000:4029–4051.

    Google Scholar 

  34. Kardon RH, Denison CE, Brown CK, Thompson HS: Critical evaluation of the cocaine test in the diagnosis of Horner’s syndrome. Arch Ophthalmol 1990, 108:384–387.

    PubMed  CAS  Google Scholar 

  35. Reede DL, Garcon E, Smoker WR, Kardon R: Horner’s syndrome: clinical and radiographic evaluation. Neuroimaging Clin N Am 2008, 18:369–385, xi.

    Article  PubMed  Google Scholar 

  36. Donahue SP, Lavin PJ, Digre K: False negative hydroxyamphetamine test in acute Horner’s syndrome. Am J Ophthalmol 1996, 122:900–901.

    PubMed  CAS  Google Scholar 

  37. Morales J, Brown SM, Abdul-Rahim AS, Crosson CE: Ocular effects of apraclonidine in Horner syndrome. Arch Ophthalmol 2000, 118:951–954.

    PubMed  CAS  Google Scholar 

  38. Koc F, Kavuncu S, Kansu T, et al.: The sensitivity and specificity of 0.5% apraclonidine in the diagnosis of oculosympathetic paresis. Br J Ophthalmol 2005, 89:1442–1444.

    Article  PubMed  CAS  Google Scholar 

  39. Watts P, Satterfield D, Lim MK: Adverse effects of apraclonidine used in the diagnosis of Horner syndrome in infants. J AAPOS 2007, 11:282–283.

    Article  PubMed  Google Scholar 

  40. Carlsen J, Zabriskie N, Known Y, et al.: Apparent central nervous system depression in infants after the use of topical brimonidine. Am J Ophthalmol 1999, 128:255–256.

    Article  PubMed  CAS  Google Scholar 

  41. Enyedi I, Freedman SF: Safety and efficacy of brimonidine in children with glaucoma. J JAAPOS 2001, 5:281–284.

    Article  CAS  Google Scholar 

  42. Bacal DA, Manche EE: The role of apraclonidine in the diagnosis of Horner syndrome in pediatric patients. Arch Ophthalmol 2004, 122:276–279.

    Article  PubMed  Google Scholar 

  43. Chen PL, Chen JT, Lu DW, et al.: Comparing efficacies of 0.5% apraclonidine with 4% cocaine in the diagnosis of Horner syndrome in pediatric patients. J Ocul Pharmacol Ther 2006, 22:182–187.

    Article  PubMed  CAS  Google Scholar 

  44. Brown SM, Aouchiche R, Freedman KA: The utility of 0.5% apraclonidine in the diagnosis of Horner syndrome. Arch Ophthalmol 2003, 121:1201–1203.

    Article  PubMed  Google Scholar 

  45. Dewan MA, Harrison AR, Lee MS: False-negative apraclonidine testing in acute Horner syndrome. Can J Ophthalmol 2009, 44:109–110.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Ophthalmology and Visual Sciences, The University of Iowa Hospitals and Clinics, 200 Hawkins Drive, Iowa City, IA, 52242, USA

    Reid Longmuir

Authors
  1. Mansoor Mughal
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Reid Longmuir
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Reid Longmuir.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Mughal, M., Longmuir, R. Current pharmacologic testing for horner syndrome. Curr Neurol Neurosci Rep 9, 384–389 (2009). https://doi.org/10.1007/s11910-009-0056-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11910-009-0056-z

Keywords

Search

Navigation